Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Contact Lenses > Euclid MAX ortho-k lens launches in US
  • Contact Lenses

Euclid MAX ortho-k lens launches in US

Ophthalmology 360
Euclid MAX ortho-k lens launches in US

An overnight orthokeratology lens, Euclid MAX (Euclid Systems Corporation), has launched in the United States, according to a press release. It is indicated for use in children and adults with progressive myopia.

“Euclid MAX is the next generation of Ortho-K,” said Euclid Systems CEO Joseph Boorady, in the press release. “Building on Euclid’s proprietary lens designs, Euclid MAX features an innovative material with a Hyper Dk of 180, the highest of any US overnight Ortho-K brand, without the compromise of lens stability. This is especially important with young healthy eyes in the closed eye environment. We are very proud and excited to introduce this combination of outstanding material characteristics and proven lens designs, which will help more patients successfully manage their myopia.”

The company will also host 2 live roundtable discussions on Wednesday, May 19, and Thursday, May 20 titled, “Shifting the Paradigm: Maximize Performance with the Next Generation of Ortho-K Lenses” on Wednesday, May 19, and Thursday, May 20. F

Read the full press release here.

Share

Related Content

  • Contact Lenses

Blue-violet filtering contact lenses improve contrast sensitivity in low light and glare

  • Spotlight Series

Spotlight on ACUVUE®

contact lens
  • Optometry

Customize contact lens selection to avoid dropout in presbyopic patients

contact lens
  • Contact Lenses

Understanding contact lens wearers’ attitudes could help decrease improper use

  • Contact Lenses

Quiz: Contact Lens-Related Complications

  • Exclusives

Novel Visual Alignment Technology for Practice Growth

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon